4.7 Letter

COVID-19 among fit patients with CLL treated with venetoclax-based combinations

Journal

LEUKEMIA
Volume 34, Issue 8, Pages 2225-2229

Publisher

SPRINGERNATURE
DOI: 10.1038/s41375-020-0941-7

Keywords

-

Funding

  1. Hoffmann-La Roche
  2. AbbVie
  3. Janssen-Cilag Ltd
  4. German CLL Study Group
  5. HOVON
  6. Nordic CLL Study Group (NCLLSG)
  7. Swiss Group for Clinical Cancer Research (SAKK)
  8. Cancer Trials Ireland
  9. Israeli CLL Study Group
  10. Projekt DEAL

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available